Trial intelligence / Profile preview

COBOX: BSA vs Concentration-based HIPEC in Colorectal Cancer

NCT03028155Phase 3Unknown

Sponsor
Hasselt University
Start
Nov 2016
Primary completion
Aug 2018
Countries
1
01

Overview

A Phase 3 trial of oxaliplatin in colorectal peritoneal carcinomatosis (CRC-PC), sponsored by Hasselt University. Status: unknown.

02

Drugs

oxaliplatin
03

Conditions

colorectal peritoneal carcinomatosis (CRC-PC)

Beyond the preview

Go deeper on NCT03028155.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03028155.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call